Pharmacoeconomic analysis of biologics and methotrexate for rheumatoid arthritis from the standpoint of the number needed to treat concept under the Japanese health insurance system
Article in Cost Effectiveness and Resource Allocation (March 2022)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Cost Effectiveness and Resource Allocation (March 2022)
Preprint in Research Square (June 2021)
Article in British Journal of Clinical Pharmacology (January 2020)